Advanced Medical Solutions Group plc (LON:AMS – Get Free Report) shares hit a new 52-week high during trading on Wednesday . The company traded as high as GBX 282 and last traded at GBX 280, with a volume of 1107860 shares. The stock had previously closed at GBX 280.
Analysts Set New Price Targets
Several research firms have recently weighed in on AMS. Royal Bank Of Canada reiterated a “sector perform” rating and issued a GBX 260 price objective on shares of Advanced Medical Solutions Group in a research note on Thursday, April 9th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a GBX 275 target price on shares of Advanced Medical Solutions Group in a research report on Friday, June 26th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 price target on shares of Advanced Medical Solutions Group in a research note on Tuesday, May 19th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Advanced Medical Solutions Group presently has a consensus rating of “Moderate Buy” and an average target price of GBX 270.25.
Check Out Our Latest Stock Report on Advanced Medical Solutions Group
Advanced Medical Solutions Group Stock Up 0.2%
Advanced Medical Solutions Group Company Profile
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.
See Also
- Five stocks we like better than Advanced Medical Solutions Group
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.
